Role of Basic Residues within or near the Predicted Transmembrane Helix 2 of the Human Breast Cancer Resistance Protein in Drug Transport

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2010-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/jpet.109.163493PMID 20203106PMCID PMC2879943
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of oligomeric state of prokaryotic rhomboid proteases

  2012cited by this paper
• Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding

  2009influential reference
• Application of the PM6 method to modeling proteins

  2009cited by this paper
• ABCG2: a perspective.

  2009influential reference
• Natural Allelic Variants of Bovine ATP-Binding Cassette Transporter ABCG2: Increased Activity of the Ser581 Variant and Development of Tools for the Discovery of New ABCG2 Inhibitors

  2009influential reference
• Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock

  2009cited by this paper
• Arginine 383 is a crucial residue in ABCG2 biogenesis.

  2009cited by this paper
• Membrane topology of the human breast cancer resistance protein (BCRP/ABCG2) determined by epitope insertion and immunofluorescence.

  2008influential reference
• Interaction with the 5D3 Monoclonal Antibody Is Regulated by Intramolecular Rearrangements but Not by Covalent Dimer Formation of the Human ABCG2 Multidrug Transporter*

  2008cited by this paper
• Oligomerization domain of the multidrug resistance-associated transporter ABCG2 and its dominant inhibitory activity.

  2007cited by this paper
• A "Silent" Polymorphism in the MDR1 Gene Changes Substrate Specificity

  2007cited by this paper
• A semiempirical free energy force field with charge‐based desolvation

  2007cited by this paper
• Purification of breast cancer resistance protein ABCG2 and role of arginine-482

  2006cited by this paper
• Functional Importance of Three Basic Residues Clustered at the Cytosolic Interface of Transmembrane Helix 15 in the Multidrug and Organic Anion Transporter MRP1 (ABCC1)*

  2006influential reference
• Mutational studies of G553 in TM5 of ABCG2: a residue potentially involved in dimerization.

  2006cited by this paper
• Purification and 3D structural analysis of oligomeric human multidrug transporter ABCG2.

  2006cited by this paper
• Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter

  2006cited by this paper
• The nature of amino acid 482 of human ABCG2 affects substrate transport and ATP hydrolysis but not substrate binding

  2006influential reference
• FUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE

  2005influential reference
• Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition.

  2005cited by this paper
• FUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE PROTEIN: I206L, N590Y, AND D620N

  2005influential reference
• Role of the breast cancer resistance protein (ABCG2) in drug transport

  2005cited by this paper
• Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2*

  2004cited by this paper
• Functional expression of the human breast cancer resistance protein in Pichia pastoris.

  2004cited by this paper
• Arginine482 to threonine mutation in the breast cancer resistance protein ABCG2 inhibits rhodamine 123 transport while increasing binding.

  2004cited by this paper
• Identification of Proline Residues in the Core Cytoplasmic and Transmembrane Regions of Multidrug Resistance Protein 1 (MRP1/ABCC1) Important for Transport Function, Substrate Specificity, and Nucleotide Interactions*

  2004cited by this paper
• Functional characterization of human breast cancer resistance protein (BCRP, ABCG2) expressed in the oocytes of Xenopus laevis.

  2003cited by this paper
• A functional study on polymorphism of the ATP-binding cassette transporter ABCG2: critical role of arginine-482 in methotrexate transport.

  2003influential reference
• Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants

  2003influential reference
• Functional and structural consequences of cysteine substitutions in the NH2 proximal region of the human multidrug resistance protein 1 (MRP1/ABCC1).

  2003influential reference
• A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2).

  2001cited by this paper
• Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells.

  2001influential reference
• Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.

  2001cited by this paper
• Helical membrane protein folding, stability, and evolution.

  2000cited by this paper
• Identification of Basic Residues Involved in Drug Export Function of Human Multidrug Resistance-associated Protein 2*

  2000cited by this paper
• Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

  1999cited by this paper
• A multidrug resistance transporter from human MCF-7 breast cancer cells.

  1998cited by this paper
• Alteration of substrate specificity by mutations at the His61 position in predicted transmembrane domain 1 of human MDR1/P-glycoprotein.

  1997influential reference
• Supporting Online Material Materials and Methods Som Text Figs. S1 to S8 Table S1 Movies S1 to S3 a " Silent " Polymorphism in the Mdr1 Gene Changes Substrate Specificity Corrected 30 November 2007; See Last Page

  year unknowncited by this paper

• Exploring the effect of intracellular loop 1 genetic variants in human ABCG2 on transport activity and protein abundance.

  2025cites this paper
• Efflux transporters in drug disposition during pregnancy.

  2024cites this paper
• ABCG2 in Acute Myeloid Leukemia: Old and New Perspectives

  2023cites this paper
• The first intracellular loop is essential for the catalytic cycle of the human ABCG2 multidrug resistance transporter

  2020cites this paper
• ABCG2 transports anticancer drugs via a closed-to-open switch

  2020cites this paper
• The study of drug resistance properties of ABCG2 (ATP-binding cassette G2) in contact with thymoquinone, gallic acid, and hesperetin antioxidants

  2019cites this paper
• High-Throughput Virtual Screening Molecular Docking Software for Students and Educators

  2018cites this paper
• Lipid regulation of placental mycotoxin transport

  2018cites this paper
• The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion

  2017cites this paper
• 2‐Trifluoromethyl‐2‐Hydroxypropionamide Derivatives as Novel Reversal Agents of ABCG2 (BCRP)‐Mediated Multidrug Resistance: Synthesis and Biological Evaluations

  2017cites this paper
• Biochemical studies on the structure–function relationship of major drug transporters in the ATP‐binding cassette family and solute carrier family☆

  2017cites this paper
• A Q141K aminosav csere hatása az ABCG2 transzporterben

  2016cites this paper
• Insights into Chemoresistance of Prostate Cancer

  2015cites this paper
• Identification of residues in ABCG2 affecting protein trafficking and drug transport, using co-evolutionary analysis of ABCG sequences

  2015cites this paper
• Determinants of the activity and substrate recognition of breast cancer resistance protein (ABCG2)

  2014influential citation
• Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update

  2014cites this paper
• Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics

  2014cites this paper
• Role of breast cancer resistance protein (BCRP) as active efflux transporter on blood-brain barrier (BBB) permeability

  2014cites this paper
• Mechanisms of resistance against cancer therapeutic drugs.

  2014cites this paper
• Heterologous expression of membrane proteins in Saccharomyces cerevisiae

  2014cites this paper
• Adjudin disrupts spermatogenesis by targeting drug transporters

  2013cites this paper
• Expression of the breast cancer resistance protein and 5-fluorouracil resistance in clinical breast cancer tissue specimens

  2013cites this paper
• Camptothecin resistance in cancer: insights into the molecular mechanisms of a DNA-damaging drug.

  2013cites this paper
• Molecular Pharmacology of ABCG2 and Its Role in Chemoresistance

  2013cites this paper
• Dockomatic: An Emerging Resource to Manage Molecular Docking

  2012cites this paper
• Accessible High-Throughput Virtual Screening Molecular Docking Software for Students and Educators

  2012cites this paper
• Identification of proline residues in or near the transmembrane helices of the human breast cancer resistance protein (BCRP/ABCG2) that are important for transport activity and substrate specificity.

  2011influential citation
• Contributions of TM5, ECL3 and TM6 of human BCRP to its oligomerization activities and transport functions

  2011cites this paper
• Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

  2010influential citation
• Targeting intestinal transporters for optimizing oral drug absorption.

  2010cites this paper
• Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport.

  2010cites this paper
• The role of ABCG2 in drug active transport in milk

  2010cites this paper
• ScholarWorks ScholarWorks

  year unknowncites this paper